Cure rates obtained with five different Helicobacter pylori eradication protocols in patients with duodenal ulcer: A prospective, open-label, randomized study in a primary care setting in Turkey

---

Atıf İçin Kopyala

Ungan M., Kulacoglu H., Kayhan B.

CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, cilt.62, sa.6, ss.462-472, 2001 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 62 Sayı: 6
• Basım Tarihi: 2001
• Doi Numarası: 10.1016/s0011-393x(01)80057-6
• Dergi Adı: CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.462-472
• Orta Doğu Teknik Üniversitesi Adresli: Hayır

Özet

Background: Helicobacter py[ori is the main causative agent in peptic ulcer disease. Duodenal ulcer disease is a chronic, recurring condition, and the risk of recurrence and complications does not diminish over time unless H pylori is eradicated. Several treatment protocols exist to eradicate H pylori, but their efficacy and costs vary. Because of regional variations in bacterial resistance and in treatment costs, primary care physicians must use the most appropriate protocol for their own region and population.